Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

A personal view of skin permeation (1960-2013).

Scheuplein RJ.

Skin Pharmacol Physiol. 2013;26(4-6):199-212. doi: 10.1159/000351954. Epub 2013 Jul 29.

PMID:
23921106
2.

Safety profile of a food dextrin: acute oral, 90-day rat feeding and mutagenicity studies.

Wils D, Scheuplein RJ, Deremaux L, Looten PH.

Food Chem Toxicol. 2008 Oct;46(10):3254-61. doi: 10.1016/j.fct.2008.06.092. Epub 2008 Jul 25.

PMID:
18701086
3.

Studies on the non-pathogenicity of Chryseobacterium proteolyticum and on the safety of the enzyme: protein-glutaminase.

Scheuplein RJ, Mizutani A, Yamaguchi S.

Regul Toxicol Pharmacol. 2007 Nov;49(2):79-89. Epub 2007 Jun 14.

PMID:
17630060
4.

Pesticides and infant risk: is there a need for an additional safety margin?

Scheuplein RJ.

Regul Toxicol Pharmacol. 2000 Jun;31(3):267-79. No abstract available.

PMID:
10915585
5.

The FQPA: a challenge for science policy and pesticide regulation.

Scheuplein RJ, Byrd DM 3rd.

Regul Toxicol Pharmacol. 2000 Jun;31(3):248-66. No abstract available. Erratum in: Regul Toxicol Pharmacol 2001 Apr;33(2):269.

PMID:
10915584
6.

Risk analysis of dietary lead exposure.

Carrington CD, Bolger PM, Scheuplein RJ.

Food Addit Contam. 1996 Jan;13(1):61-76.

PMID:
8647308
7.

Information needed to support hazard identification and risk assessment of toxic substances.

Scheuplein RJ.

Toxicol Lett. 1995 Sep;79(1-3):23-8. Review.

PMID:
7570661
8.

Delaney reform.

Cohen SM, Clydesdale FM, Winter C, Graham JD, Weil WB Jr, Kroger M, Pariza MW, Crawford LM, Avery D, Scheuplein RJ, et al.

Science. 1995 Jun 30;268(5219):1829-30. No abstract available. Erratum in: Science 1995 Sep 22;269(5231):1657.

PMID:
7604249
9.

Use of 'secondary mechanism' in the regulation of carcinogens; a chronology.

Scheuplein RJ.

Cancer Lett. 1995 Jun 29;93(1):103-12. Review.

PMID:
7600537
10.

Dioxin--an analysis of the major human studies: comparison with animal-based cancer risks.

Scheuplein RJ, Bowers JC.

Risk Anal. 1995 Jun;15(3):319-33.

PMID:
7604166
11.

The use of biological data in addition to the carcinogen bioassay in quantitative risk assessment.

Scheuplein RJ.

Prog Clin Biol Res. 1995;391:347-57. No abstract available.

PMID:
8532727
12.

Point estimates of cancer risk at low doses.

Gaylor DW, Kodell RL, Chen JJ, Springer JA, Lorentzen RJ, Scheuplein RJ.

Risk Anal. 1994 Oct;14(5):843-50.

PMID:
7800868
13.

Use of cell proliferation data in cancer risk assessment: FDA view.

Scheuplein RJ.

Environ Health Perspect. 1993 Dec;101 Suppl 5:139-41.

14.

U.S. Food and Drug Administration approach to risk assessment of aflatoxin in human foods.

Henry SH, Scheuplein RJ, Bowers J, Tollefson L.

Qual Assur. 1993 Mar-Jun;2(1-2):71-7. No abstract available.

PMID:
8156225
15.

Perspectives on toxicological risk--an example: foodborne carcinogenic risk.

Scheuplein RJ.

Crit Rev Food Sci Nutr. 1992;32(2):105-21. Review.

PMID:
1515037
16.

Regulation of carcinogens and mutagens in foods in the United States.

Prival MJ, Scheuplein RJ.

Prog Clin Biol Res. 1990;347:307-21. No abstract available.

PMID:
2217399
17.

Role of pharmacokinetics in safety evaluation and regulatory considerations.

Scheuplein RJ, Shoaf SE, Brown RN.

Annu Rev Pharmacol Toxicol. 1990;30:197-218. Review. No abstract available.

PMID:
2188568
18.

Panel discussion: Risk assessment associated with the use of phenolic antioxidants in foods.

Blumenthal H, Daniel JW, Elias PS, Scheuplein RJ, Silano V, Turturro A, Vettorazzi G.

Food Chem Toxicol. 1986 Oct-Nov;24(10-11):1243-53. No abstract available.

PMID:
3804127
19.

The role of risk assessment in food safety policy.

Scheuplein RJ.

Basic Life Sci. 1986;38:563-71. No abstract available.

PMID:
3741348
20.

An evaluation of skin painting studies as determinants of tumorigenesis potential following skin contact with carcinogens.

Tobin PS, Kornhauser A, Scheuplein RJ.

Regul Toxicol Pharmacol. 1982 Mar;2(1):22-37. No abstract available.

PMID:
7186159
21.

The effect of cosmetic vehicles on the penetration of N-nitrosodiethanolamine through excised human skin.

Bronaugh RL, Congdon ER, Scheuplein RJ.

J Invest Dermatol. 1981 Feb;76(2):94-6.

22.

Permeability of the skin: a review of major concepts.

Scheuplein RJ.

Curr Probl Dermatol. 1978;7:172-86. No abstract available.

PMID:
752452
23.
24.

Mechanism of percutaneous absorption. V. Percutaneous absorption of solvent deposited solids.

Scheuplein RJ, Ross LW.

J Invest Dermatol. 1974 Apr;62(4):353-60. No abstract available.

25.
26.

Effects of ionic surfactants on the permeability of human epidermis: an electrometric study.

Dugard PH, Scheuplein RJ.

J Invest Dermatol. 1973 May;60(5):263-9. No abstract available.

27.

Properties of the skin as a membrane.

Scheuplein RJ.

Adv Biol Skin. 1972;12:125-52. Review. No abstract available.

PMID:
4579188
28.

Permeability of the skin.

Scheuplein RJ, Blank IH.

Physiol Rev. 1971 Oct;51(4):702-47. Review. No abstract available.

PMID:
4940637
29.

Percutaneous absorption of steroids.

Scheuplein RJ, Blank IH, Brauner GJ, MacFarlane DJ.

J Invest Dermatol. 1969 Jan;52(1):63-70. No abstract available.

30.

On the application of rate theory to complex multibarrier flow co-ordinates: membrane permeability.

Scheuplein RJ.

J Theor Biol. 1968 Jan;18(1):72-89. No abstract available.

PMID:
5648883
31.

Mechanism of percutaneous absorption. 3. The effect of temperature on the transport of non-electrolytes across the skin.

Blank IH, Scheuplein RJ, MacFarlane DJ.

J Invest Dermatol. 1967 Dec;49(6):582-9. No abstract available.

32.

"Bound water" in keratin membranes measured by a microbalance technique.

Scheuplein RJ, Morgan LJ.

Nature. 1967 Apr 29;214(5087):456-8. No abstract available.

PMID:
6032864
33.
34.
35.

Mechanism of percutaneous adsorption. I. Routes of penetration and the influence of solubility.

Scheuplein RJ.

J Invest Dermatol. 1965 Nov;45(5):334-46. No abstract available.

Supplemental Content

Loading ...
Support Center